Onco Wiki / Indication

Ovarian carcinoma (high-grade serous predominant) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Trackaggressive
Linked regimenNone
IDIND-BRIP1-SUSPICION-PREVENTION-EMPIRICAL-SURVEILLANCE
TypeIndication
Statusreviewed 2026-05-19 | pending_clinical_signoff
DiseasesDIS-OVARIAN
SourcesSRC-NCCN-GENETIC-FAMILIAL-BREAST-OVARIAN-2025 SRC-NCCN-OVARIAN-2025

Notes

STUB — aggressive-track companion for BRIP1 hereditary prevention suspicion pilot. §15.2 C4 ≥2-tracks invariant compliance. v0.3 Wave M.

Used By

Indication